Vyro Bio

0 followers

‌

Vyro develops oncolytic viruses designed to target CNS tumors, based on pioneering research on the oncolytic properties of the Zika Virus.

Industries

Headquarters

Employees

Links

Org chart

Hugo Cabrera

CEO & Co-Founder

Hugo Cabrera

Collapse

Co-founder

COO

Marketing Assistant

Administrative Assistant

Fabiane Honório

Laboratory Technician

Teams

Scientific and Medical Team

8 members

Leadership Team

4 members

Similar companies

Neogene Therapeutics

2 followers

GRAIL

27 followers

Cytokinetics

11 followers

Ascendis Pharma

8 followers

Emergent BioSolutions

4 followers

Synthekine

3 followers

GOURMEY

19 followers

BridgeBio

2 followers

Forge Biologics

2 followers

Universal Diagnostics

2 followers

Obsidian Therapeutics

1 follower

Discover companies